Please assess the completion status of the following clinical trial:

Trial Title: Improving Anticoagulation Control in VISN 1

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All patients receiving long-term oral anticoagulation with warfarin within the VA New England Region (VISN 1)~Exclusion Criteria:~* Patients with valvular heart disease, who may have an INR target range other than 2-3. This usually represents between 10-15% of patients receiving anticoagulation.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention Group (Type: EXPERIMENTAL): VA patients treated at anticoagulation clinics at 8 sites in VISN 1. The intervention included a system to measure processes of care relevant to warfarin management, along with targeted audit and feedback.
- Control Group (Type: NO_INTERVENTION): VA patients treated at anticoagulation clinics at 116 sites outside of VISN 1.

Based on this trial design, predict the completion outcome and termination type (if applicable).